Gil D Rabinovici

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
    G D Rabinovici
    UCSF Memory and Aging Center, San Francisco, CA 94143, USA
    Neurology 77:2034-42. 2011
  2. ncbi Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo
    G D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Behav Neurol 21:117-28. 2009
  3. ncbi Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management
    Gil D Rabinovici
    Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA
    CNS Drugs 24:375-98. 2010
  4. ncbi Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia
    Gil D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Ann Neurol 64:388-401. 2008
  5. ncbi Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration
    G D Rabinovici
    Memory and Aging Center, University of California, San Francisco, California 94143, USA
    Am J Alzheimers Dis Other Demen 22:474-88. 2007
  6. ncbi 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
    G D Rabinovici
    Memory and Aging Center, University of California San Fransisco, San Francisco, CA 94117, USA
    Neurology 68:1205-12. 2007
  7. ncbi Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden
    Gil D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Brain 133:512-28. 2010
  8. ncbi Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
    Ansgar J Furst
    Helen Wills Neuroscience Institute, 132 Barker Hall, University of California, Berkeley, Berkeley, CA 94720, USA
    Neurobiol Aging 33:215-25. 2012
  9. ncbi Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
    E C Mormino
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
    Brain 132:1310-23. 2009
  10. ncbi Clinicopathological correlations in corticobasal degeneration
    Suzee E Lee
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Ann Neurol 70:327-40. 2011

Detail Information

Publications18

  1. ncbi Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
    G D Rabinovici
    UCSF Memory and Aging Center, San Francisco, CA 94143, USA
    Neurology 77:2034-42. 2011
    ..To compare the diagnostic performance of PET with the amyloid ligand Pittsburgh compound B (PiB-PET) to fluorodeoxyglucose (FDG-PET) in discriminating between Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD)...
  2. ncbi Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo
    G D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Behav Neurol 21:117-28. 2009
    ..In the future, amyloid imaging is likely to supplement clinical evaluation in selecting patients for anti-amyloid therapies, while MRI and FDG-PET may be more appropriate markers of clinical progression...
  3. ncbi Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management
    Gil D Rabinovici
    Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA
    CNS Drugs 24:375-98. 2010
    ..However, recent advances in FTLD genetics and molecular pathology make the prospect of biologically driven, disease-specific therapies for FTLD seem closer than ever...
  4. ncbi Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia
    Gil D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Ann Neurol 64:388-401. 2008
    ....
  5. ncbi Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration
    G D Rabinovici
    Memory and Aging Center, University of California, San Francisco, California 94143, USA
    Am J Alzheimers Dis Other Demen 22:474-88. 2007
    ..001, uncorrected). These findings suggest that AD and FTLD are anatomically distinct, with degeneration of a posterior parietal network in AD and degeneration of a paralimbic fronto-insular-striatal network in FTLD...
  6. ncbi 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
    G D Rabinovici
    Memory and Aging Center, University of California San Fransisco, San Francisco, CA 94117, USA
    Neurology 68:1205-12. 2007
    ..We hypothesized that PET imaging with (11)C-PIB would discriminate AD from frontotemporal lobar degeneration (FTLD), a non-Abeta dementia...
  7. ncbi Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden
    Gil D Rabinovici
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Brain 133:512-28. 2010
    ..Our data are consistent with a model in which both early amyloid-beta accumulation and increased vulnerability to amyloid-beta pathology play critical roles in the pathogenesis of Alzheimer's disease in young patients...
  8. ncbi Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
    Ansgar J Furst
    Helen Wills Neuroscience Institute, 132 Barker Hall, University of California, Berkeley, Berkeley, CA 94720, USA
    Neurobiol Aging 33:215-25. 2012
    ..Finally, there were no associations between regional PIB and FDG uptake. We conclude that regional and global amyloid burden does not correlate with clinical status or glucose metabolism in AD...
  9. ncbi Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
    E C Mormino
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
    Brain 132:1310-23. 2009
    ..This pattern suggests that declining EM in older individuals may be caused by Abeta-induced hippocampus atrophy...
  10. ncbi Clinicopathological correlations in corticobasal degeneration
    Suzee E Lee
    Memory and Aging Center, University of California San Francisco, San Francisco, CA 94143, USA
    Ann Neurol 70:327-40. 2011
    ..To characterize cognitive and behavioral features, physical findings, and brain atrophy patterns in pathology-proven corticobasal degeneration (CBD) and corticobasal syndrome (CBS) with known histopathology...
  11. ncbi Sporadic corticobasal syndrome due to FTLD-TDP
    Maria Carmela Tartaglia
    Memory and Aging Center, Department of Neurology, University of California, 1207, 350 Parnassus Ave, Ste 905, San Francisco, CA 94143 1207, USA
    Acta Neuropathol 119:365-74. 2010
    ..These findings confirm that FTLD-TDP should be included in the pathological differential diagnosis for sporadic CBS...
  12. ncbi Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease
    Juan Zhou
    Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94117, USA
    Brain 133:1352-67. 2010
    ..Further developed, intrinsic connectivity network signatures may provide simple, inexpensive, and non-invasive biomarkers for dementia differential diagnosis and disease monitoring...
  13. ncbi Seizures in corticobasal degeneration: a case report
    Vanja C Douglas
    University of California Department of Neurology Box 0114 400 Parnassus Ave, 8th Floor Neurology Clinic San Franciso, CA 94143 0114, USA
    Neurocase 15:352-6. 2009
    ..Thus, the occurrence of seizures in a patient with dementia should not exclude the diagnosis of CBD...
  14. ncbi Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease
    A L Boxer
    Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143 1207, USA
    Neurology 69:283-90. 2007
    ..To compare the in vivo uptake of two amyloid-binding PET agents, PIB and FDDNP, in human subjects with a prion protein (PrP) gene (PRNP) mutation that produces a clinical syndrome similar to Alzheimer disease (AD)...
  15. ncbi Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum
    R Migliaccio
    Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143 1207, USA
    Neurology 73:1571-8. 2009
    ..We compared PCA and LPA to each other and to an age-matched group of patients with early age at onset of Alzheimer disease (EO-AD). We hypothesized that these 3 syndromes are part of a single clinical and biologic continuum...
  16. ncbi Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB)
    Michael H Rosenbloom
    Department of Neurology, University of California, San Francisco Memory and Aging Center, San Francisco, CA, USA
    Alzheimer Dis Assoc Disord 24:209-11. 2010
    ..Owing to underlying autonomic dysfunction, patients with DLB may be at increased risk of bradyarrhythmia resulting from treatment with acetylcholinesterase inhibitors...
  17. ncbi Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration
    E J Kim
    Memory and Aging Center, and Department of Neurology, University of California, San Francisco, San Francisco, California 94117, USA
    J Neurol Neurosurg Psychiatry 78:1375-8. 2007
    ..Manual region of interest tracing of caudate and putamen volumes confirmed the VBM findings. These anatomical differences may help distinguish between FTLD spectrum pathological subtypes in vivo...
  18. ncbi First symptom in sporadic Creutzfeldt-Jakob disease
    G D Rabinovici
    Department of Neurology, University of California, San Francisco, CA, USA
    Neurology 66:286-7. 2006